[Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus]. 1983

H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng

A total of 90 isolates of Haemophilus were studied for susceptibility to tetracycline, doxycycline and minocycline. In vitro activity was determined by agar dilution method (MIC) and disk diffusion test. Disk diffusion tests were done on chocolate agar and on supplemented Mueller-Hinton agar. MICs rang from greater than or equal to 128 to 0,25, 32 to 0,5 and 32 to 0,25 micrograms/ml for tetracycline, doxycycline and minocycline respectively. Strains can be divided into tetracycline-sensitive strains which are inhibited by concentration less than or equal to 2 micrograms/ml and tetracycline-resistant strains inhibited by greater than or equal to 16 micrograms/ml. Sensitive strains are inhibited by 0,5-1 microgram/ml of doxycycline and 0,25-2 micrograms/ml of minocycline. Resistant strains are inhibited by concentrations from 2 to 32 micrograms/ml of doxycycline and from 0,5 to 32 micrograms/ml of minocycline. All but one resistant strains were inhibited by a concentration of less than or equal to 4 micrograms/ml of minocycline; all but two resistants strains were inhibited by doxycycline at a concentration greater than or equal to 4 micrograms/ml. The correlation coefficients are the following: for tetracycline, r = -0,95; for doxycycline r = -0,83 when disk diffusion test is done on supplemented Mueller-Hinton and r = -0,94 on chocolate agar; for minocycline r = -0,62 on supplemented Muller-Hinton and r = -0,75 on chocolate agar.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008911 Minocycline A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. Akamin,Akne-Puren,Aknemin,Aknin-Mino,Aknosan,Apo-Minocycline,Arestin,Blemix,Cyclomin,Cyclops,Dentomycin,Dynacin,Icht-Oral,Klinomycin,Lederderm,Mestacine,Minakne,Mino-Wolff,Minocin,Minocin MR,Minoclir,Minocycline Hydrochloride,Minocycline Monohydrochloride,Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,Minolis,Minomycin,Minoplus,Minotab,Minox 50,Mynocine,Akne Puren,Aknin Mino,Apo Minocycline,Hydrochloride, Minocycline,Icht Oral,Mino Wolff,Monohydrochloride, Minocycline
D004318 Doxycycline A synthetic tetracycline derivative with similar antimicrobial activity. 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-,Alpha-6-Deoxyoxytetracycline,Atridox,BMY-28689,BU-3839T,Doryx,Doxycycline Calcium,Doxycycline Calcium Salt (1:2),Doxycycline Hemiethanolate,Doxycycline Hyclate,Doxycycline Monohydrate,Doxycycline Monohydrochloride, 6-epimer,Doxycycline Monohydrochloride, Dihydrate,Doxycycline Phosphate (1:1),Doxycycline-Chinoin,Hydramycin,Oracea,Periostat,Vibra-Tabs,Vibramycin,Vibramycin Novum,Vibravenos,Alpha 6 Deoxyoxytetracycline,BMY 28689,BMY28689,BU 3839T,BU3839T,Doxycycline Chinoin,Doxycycline Monohydrochloride, 6 epimer,Vibra Tabs
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006190 Haemophilus A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile. Hemophilus
D013752 Tetracycline A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. 4-Epitetracycline,Achromycin,Achromycin V,Hostacyclin,Sustamycin,Tetrabid,Tetracycline Hydrochloride,Tetracycline Monohydrochloride,Topicycline,4 Epitetracycline
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)

Related Publications

H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
October 1997, Archives of dermatology,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
October 1974, Antimicrobial agents and chemotherapy,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
January 1975, Antimicrobial agents and chemotherapy,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
January 1974, British medical journal,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
November 1972, International journal of clinical pharmacology, therapy and toxicology,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
April 2023, Advances in therapy,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
April 1975, Lancet (London, England),
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
June 1985, Pathologie-biologie,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
January 1975, International journal of clinical pharmacology and biopharmacy,
H Dabernat, and C Delmas, and R Bauriaud, and M B Lareng
September 1987, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!